Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 648

BillFederalSenateIn Committee
Medicare Formulary Improvement Act of 2015
About This Bill
Committee
Latest Action · March 4, 2015
Read twice and referred to the Committee on Finance.
Congress
114th (2015–2017)
Introduced
March 4, 2015
Cosponsors (2)
2D 0R
View PDF ↗

Summary

Highlight any text to annotate
Medicare Formulary Improvement Act of 2015 This bill amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to require a sponsor offering a prescription drug plan (PDP) to include all covered part D drugs in the following categories and classes of drugs in the formulary: (1) anticonvulsants, (2) antidepressants, (3) antineoplastics, (4) antipsychotics, (5) antiretrovirals, and (6) immunosuppressants for the treatment of transplant rejection. Currently the Secretary of Health and Human Services is required to identify categories and classes of drugs of clinical concern. The Secretary is required, however, to establish any exceptions that permit a PDP sponsor to exclude from its formulary a particular covered part D drug only through promulgation of a regulation, including a public notice and comment period.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.